Fluoxetine Hydro Chloride

fluoxetine hydrochloride
(floo ox' e teen)

Apo-Fluoxetine (CAN), Novo-Fluoxetine (CAN), PMS-Fluoxetine (CAN),
Prozac, Prozac Weekly, Sarafem
Pregnancy Category B
Drug classes
Antidepressant
SSRI
Therapeutic actions
Acts as an antidepressant by inhibiting CNS neuronal uptake of serotonin; blocks uptake
of serotonin with little effect on norepinephrine; little affinity for muscarinic,
histaminergic, and alpha1-adrenergic receptors.
Indications
• Treatment of depression; most effective in patients with major depressive disorder
• Treatment of obsessive-compulsive disorder
• Treatment of bulimia
• Sarafem: Treatment of PMDD (pre-menstrual dysphoric disorder)
• Prozac: Treatment of panic disorder with or without agoraphobia
• Unlabeled use: Treatment of obesity, alcoholism, numerous psychiatric disorders,
chronic pain, various neuropathies
Contraindications and cautions

• Contraindicated with hypersensitivity to fluoxetine, pregnancy.
• Use cautiously with impaired hepatic or renal function, diabetes mellitus,
lactation, seizures.
Available forms
Tablets—10, 20 mg; pulvules—10, 20, 40 mg; liquid—20 mg/5 mL; DR capsules—
90 mg
Dosages
ADULTS
• Antidepressant: The full antidepressant effect may not be seen for up to 4 wk.
Initially, 20 mg/day PO in the morning. If no clinical improvement is seen,
increase dose after several weeks. Administer doses > 20 mg/day on a bid
schedule. Do not exceed 80 mg/day. Once stabilized, may switch to 90-mg DR
capsules once a week.
• Obsessive-compulsive disorder: Initially, 20 mg/day PO. If no clinical
improvement is seen, increase dose after several weeks. Usual dosage range, 20–
60 mg/day; may require up to 5 wk for effectiveness. Do not exceed 80 mg/day.
• Bulimia: 60 mg/day PO in the morning.
• PMDD (Sarafem): 20 mg/day PO or 20 mg/day PO starting 14 days prior to the
anticipated beginning of menses and continuing through the first full day of
menses, then no drug until 14 days before next menses; do not exceed 80 mg/day.
• Panic disorder (Prozac): 10 mg/day PO for the first week, increase to 20 mg/day
if needed. Maximum dose, 60 mg/day.
PEDIATRIC PATIENTS
< 7 yr: Safety and efficacy not established.
7–17 yr:
• Major depressive order: 10 mg/day PO; may be increased to 20 mg/day after
several weeks.
• Obsessive-compulsive disorder: Initially, 10 mg/day PO. After 2 wk increase to
20–60 mg/day.
GERIATRIC PATIENTS OR PATIENTS WITH HEPATIC OR RENAL IMPAIRMENT
Give a lower or less frequent dose. Monitor response to guide dosage.
Pharmacokinetics
Route Onset Peak
Oral Slow 6–8 hr
Metabolism: Hepatic; T1/2: 2–9 days

Distribution: Crosses placenta; enters breast milk
Excretion: Urine and feces
Adverse effects
• CNS: Headache, nervousness, insomnia, drowsiness, anxiety, tremor, dizziness,
light-headedness, agitation, sedation, abnormal gait, seizures
• CV: Hot flashes, palpitations
• Dermatologic: Sweating, rash, pruritus, acne, alopecia, contact dermatitis
• GI: Nausea, vomiting, diarrhea, dry mouth, anorexia, dyspepsia, constipation,
taste changes, flatulence, gastroenteritis, dysphagia, gingivitis
• GU: Painful menstruation, sexual dysfunction, frequency, cystitis, impotence,
urgency, vaginitis
• Respiratory: Upper respiratory infections, pharyngitis, cough, dyspnea,
bronchitis, rhinitis
• Other: Weight loss, asthenia, fever
Interactions
Drug-drug
• Increased therapeutic and toxic effects of TCAs
• Do not use with thioridazine (increased levels of thioridazine)
• Decreased effectiveness if taken while smoking
• Increased toxicity of lithium; avoid this combination
• Possible fatal reactions with MAOIs; do not administer together; 2-wk washout
period needed
• Additive CNS effects if combined with benzodiazepines, alcohol; avoid these
combinations
• Avoid administration with other serotonergic drugs; may lead to serotonin
syndrome
Drug-alternative therapy
• Increased risk of severe reaction if combined with St. John's wort therapy.
Nursing considerations
CLINICAL ALERT!
Name confusion has been reported between Sarafem (fluoxetine) and
Serophene (clomiphene); use caution.
Assessment
• History: Hypersensitivity to fluoxetine, impaired hepatic or renal function,
diabetes mellitus, lactation, pregnancy, seizures
• Physical: Weight, T; skin rash, lesions; reflexes, affect; bowel sounds, liver
evaluation; P, peripheral perfusion; urinary output, renal and liver function tests,
CBC
Interventions
• Arrange for lower or less frequent doses in elderly patients and patients with
hepatic or renal impairment.
• Establish suicide precautions for severely depressed patients. Limit quantity of
capsules dispensed.
• Administer drug in the morning. If dose of > 20 mg/day is needed, administer in
divided doses.
• Monitor patient for response to therapy for up to 4 wk before increasing dose.
• Switch to once a week therapy by starting weekly dose 7 days after last
20 mg/day dose. If response is not satisfactory, reconsider daily dosing.
Teaching points
• It may take up to 4 wk before the full effect occurs. Take in the morning (or in
divided doses if necessary). If you are taking the once weekly capsule, mark
calendar with reminders of drug day.
• Do not take this drug during pregnancy. If you think that you are pregnant or wish
to become pregnant, consult with your physician.
• These side effects may occur: Dizziness, drowsiness, nervousness, insomnia
(avoid driving or performing hazardous tasks); nausea, vomiting, weight loss (eat
frequent small meals; monitor your weight loss); sexual dysfunction; flulike
symptoms.
• Report rash, mania, seizures, severe weight loss.
• Keep this drug, and all medications, out of the reach of children.
Adverse effects in Italic are most common; those in Bold are life-threatening.

Fluoxetine Hydro Chloride

Uploaded by

Copyright:

Available Formats

Fluoxetine Hydro Chloride

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Fluoxetine Hydro Chloride

Uploaded by

Copyright:

Available Formats

fluoxetine hydrochloride

(floo ox' e teen)

Contraindications and cautions

Metabolism: Hepatic; T1/2: 2–9 days

You might also like